Moreover, an increase in the serum levels of biomarkers (i.e., ICAM-1, PECAM-1, NSE) and changes in functional connectivity together might indicate a complex lesion of the central nervous system in VAS in patients in the long-term period following breast cancer treatment. The gene discussed is ENO2; the disease is breast cancer.